Sage Therapeutics to Participate in Cowen’s Psychedelics & Novel Mechanisms in Neuropsychiatry Summit

Rhea-AI Summary

Sage Therapeutics, Inc. (NASDAQ: SAGE) has announced its participation in a fireside chat at Cowen’s Psychedelics & Novel Mechanisms in Neuropsychiatry Summit on July 13 at 2:25 PM ET. This event is part of the company's ongoing commitment to develop novel therapies for brain disorders. A live webcast of the presentation will be available on Sage's investor page, with an archived replay accessible for 30 days post-event. Sage aims to transform the treatment of debilitating brain disorders through innovative approaches in neurology and neuropsychiatry.

Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, today announced that the Company will participate in a fireside chat at Cowen’s Psychedelics & Novel Mechanisms in Neuropsychiatry Summit on July 13^th at 2:25pm ET.

A live webcast of the presentation can be accessed on the investor page of Sage's website at investor.sagerx.com. A replay of the webcast will be available approximately two hours after the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics
Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health, and our depression, neurology and neuropsychiatry franchise programs aim to change how brain disorders are thought about and treated. Our mission is to make medicines that matter so people can get better, sooner. For more information, please visit www.sagerx.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210708005048/en/

FAQ

What is the date and time of Sage Therapeutics' participation in Cowen's Summit?

Sage Therapeutics will participate in Cowen’s Psychedelics & Novel Mechanisms in Neuropsychiatry Summit on July 13 at 2:25 PM ET.

Where can I watch the Sage Therapeutics presentation live?

The live webcast of the Sage Therapeutics presentation can be accessed on their investor page at investor.sagerx.com.

Will there be a replay available for the Sage Therapeutics presentation?

Yes, a replay of the Sage Therapeutics presentation will be available approximately two hours after the event and archived for 30 days.

What is the focus of Sage Therapeutics' research and development?

Sage Therapeutics is focused on developing novel therapies to transform the treatment of debilitating brain disorders.